The shares of the leading Pharma company specializing in the manufacture and supply of cellulose-based excipients, primarily microcrystalline cellulose (MCC), are in focus as they have rallied upto 40 percent in the last two trading sessions.
With a market capitalization of Rs. 1,629.73 crores on Friday, the shares of Sigachi Industries Ltd jumped upto 16 percent, making a high of Rs. 43.81 per share compared to its previous closing price of Rs. 37.77 per share.
What Happened
Sigachi Industries Ltd, engaged in the manufacture and supply of cellulose-based excipients, primarily microcrystalline cellulose (MCC), has been in focus as they have rallied upto 40 percent in the last two trading sessions.
Here are the possible reasons for the rise
Positive India-U.S. Trade Sentiment: Sigachi Industries, a pharmaceutical stock with exposure to U.S. exports, has seen a rally likely driven by recent positive statements from both the Indian and U.S. administrations about progress in the India-U.S. trade deal.
Record Date for Dividend: Sigachi Industries has set September 16, 2025, as the record date for its ₹0.10 per share dividend (10% of face value), as approved in its AGM on September 1.
Heavy Trading Activity: On Friday, 2.56 crore shares of Sigachi Industries were traded on the stock exchanges, marking a significant spike in trading activity. This high volume of trades led to a total turnover of ₹107.76 crores, indicating strong investor interest and momentum in the stock. However, the rally is entirely speculative as nothing concrete has come out from the recent company meeting.
Financials & Others
The company’s revenue rose by 34.00 percent from Rs. 96 crore to Rs. 128 crore in Q1FY25-26. Meanwhile, Net profit went from a profit of Rs. 13 crore to a loss of Rs. 101crore during the same period.
Sigachi Industries Limited is a global pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs), intermediates, excipients, vitamin-mineral blends, and operations services. With manufacturing facilities in Telangana, Gujarat, and Karnataka, and subsidiaries in the UAE and the USA, Sigachi stays close to its clients for better service.
The company focuses on innovation, quality, and regulatory compliance, using advanced technology to create high-value pharma and nutrition products. With 36 years of experience, Sigachi serves pharmaceutical and nutraceutical companies in over 65 countries, working closely with healthcare partners and regulators to provide reliable, high-quality ingredients worldwide.
Sigachi Industries offers a wide range of products and services, including pharmaceutical excipients, active pharmaceutical ingredients (APIs), film coatings, polymer blends, food and nutrition products, as well as operations and management solutions.
Written by Sridhar J
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
